R-equol, a synthetic metabolite of the dietary estrogen daidzein, modulates the nongenomic estrogenic effects of 17β-estradiol in pituitary tumor cells

References

• Fletcher RJ. Food sources of phyto-oestrogens and their precursors in Europe. Br J Nutr 2003; 89 Suppl 1:S39-43; PMID:12725655; http://dx.doi.org/10.1079/BJN2002740
   PubMed Web of Science ®Google Scholar
• Cornwell T, Cohick W, Raskin I: Dietary phytoestrogens and health. Phytochemistry 2004; 65(8):995-1016
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutri 2001; 131:1362s-75s; PMID:11285356
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003; 133(4):1027-35; PMID:12672914
   PubMed Web of Science ®Google Scholar
• Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr 2010; 140(7):1355S-62S; PMID:20519412; http://dx.doi.org/10.3945/jn.109.119776
   PubMed Web of Science ®Google Scholar
• Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr 2010; 140(7):1363S-8S; PMID:20519411; http://dx.doi.org/10.3945/jn.109.119784
   PubMed Web of Science ®Google Scholar
• Setchell KD, Brown NM, Summer S, King EC, Heubi JE, Cole S, Guy T, Hokin B. Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults. J Nutr 2013; 143(12):1950-8; PMID:24089421; http://dx.doi.org/10.3945/jn.113.179564
   PubMed Web of Science ®Google Scholar
• Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors α and β. Bioorg Med Chem 2004; 12(6):1559-67; PMID:15018930; http://dx.doi.org/10.1016/j.bmc.2003.11.035
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der BB, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998; 139(10):4252-63; PMID:9751507
   PubMed Web of Science ®Google Scholar
• Shinkaruk S, Carreau C, Flouriot G, Bennetau-Pelissero C, Potier M. Comparative effects of R- and S-equol and implication of transactivation functions (AF-1 and AF-2) in estrogen receptor-induced transcriptional activity. Nutrients 2010; 2(3):340-54; PMID:22254026; http://dx.doi.org/10.3390/nu2030340
   PubMed Web of Science ®Google Scholar
• Dutertre M, Smith CL. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 2000; 295(2):431-7; PMID:11046073
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999; 85(1):47-51; PMID:10428321; http://dx.doi.org/10.1016/S0301-2115(98)00281-4
   PubMed Web of Science ®Google Scholar
• Pugazhendhi D, Watson KA, Mills S, Botting N, Pope GS, Darbre PD. Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells. J Endocrinol 2008; 197(3):503-15; PMID:18492816; http://dx.doi.org/10.1677/JOE-07-0384
   PubMed Web of Science ®Google Scholar
• Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011, 127(3-5):204-15; PMID:21899826; http://dx.doi.org/10.1016/j.jsbmb.2011.08.007
   PubMed Web of Science ®Google Scholar
• Jeng YJ, Kochukov MY, Watson CS. Membrane estrogen receptor-α-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal 2009; 4:2; PMID:19400946; http://dx.doi.org/10.1186/1750-2187-4-2
   PubMedGoogle Scholar
• Jeng YJ, Kochukov M, Nauduri D, Kaphalia BS, Watson CS. Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol - pituitary tumor induction in Fischer 344 rats. NutrMetab (Lond) 2010; 7:40; http://dx.doi.org/10.1186/1743-7075-7-40
   PubMed Web of Science ®Google Scholar
• Ruggiero RJ, Likis FE. Estrogen: physiology, pharmacology, and formulations for replacement therapy. J Midwifery Womens Health 2002; 47(3):130-8; PMID:12071379; http://dx.doi.org/10.1016/S1526-9523(02)00233-7
   PubMed Web of Science ®Google Scholar
• Bilal I, Chowdhury A, Davidson J, Whitehead S. Phytoestrogens and prevention of breast cancer: The contentious debate. World J Clin Oncol 2014; 5(4):705-12; PMID:25302172; http://dx.doi.org/10.5306/wjco.v5.i4.705
   PubMedGoogle Scholar
• Hwang KA, Choi KC. Anticarcinogenic effects of dietary phytoestrogens and their chemopreventive mechanisms. Nutr Cancer 2015; 67(5):796-803; PMID:25996655; http://dx.doi.org/10.1080/01635581.2015.1040516
   PubMed Web of Science ®Google Scholar
• Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Gronberg H, et al. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 2006; 17(2):169-80; PMID:16425095; http://dx.doi.org/10.1007/s10552-005-0342-2
   PubMed Web of Science ®Google Scholar
• Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E: Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20(2):308-17; PMID:21098648; http://dx.doi.org/10.1158/1055-9965.EPI-10-0752
   PubMed Web of Science ®Google Scholar
• Sirtori CR, Arnoldi A, Johnson SK: Phytoestrogens: end of a tale? Ann Med 2005; 37(6):423-38; PMID:16203615; http://dx.doi.org/10.1080/07853890510044586
   PubMed Web of Science ®Google Scholar
• Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85(22):1819-27; PMID:8230262; http://dx.doi.org/10.1093/jnci/85.22.1819
   PubMed Web of Science ®Google Scholar
• Albert A, Altabre C, Baro F, Buendia E, Cabero A, Cancelo MJ, Castelo-Branco C, Chantre P, Duran M, Haya J, et al. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 2002; 9(2):85-92; PMID:11995954
   PubMed Web of Science ®Google Scholar
• Bhakta D, Higgins CD, Sevak L, Mangtani P, Adlercreutz H, McMichael AJ, dos Santos Silva I. Phyto-oestrogen intake and plasma concentrations in South Asian and native British women resident in England. Br J Nutr 2006; 95(6):1150-8; PMID:16768838; http://dx.doi.org/10.1079/BJN20061777
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Hamalainen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT: Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 1989; 49(3):433-42; PMID:2923075
   PubMed Web of Science ®Google Scholar
• Adlercreutz H: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 1990; 201:3-23; PMID:2173856; http://dx.doi.org/10.1080/00365519009085798
   PubMedGoogle Scholar
• Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997; 29(2):95-120; PMID:9187225; http://dx.doi.org/10.3109/07853899709113696
   PubMed Web of Science ®Google Scholar
• Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 2004; 134(5):1207S-12S; PMID:15113973
   PubMed Web of Science ®Google Scholar
• Heinonen SM, Hoikkala A, Wahala K, Adlercreutz H. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 2003; 87(4-5):285-99; PMID:14698210; http://dx.doi.org/10.1016/j.jsbmb.2003.09.003
   PubMed Web of Science ®Google Scholar
• Watson CS, Bulayeva NN, Wozniak AL, Finnerty CC. Signaling from the membrane via membrane estrogen receptor-α: estrogens, xenoestrogens, and phytoestrogens. Steroids 2005; 70(5-7):364-71; PMID:15862819; http://dx.doi.org/10.1016/j.steroids.2005.03.002
   PubMed Web of Science ®Google Scholar
• Watson CS, Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 1999; 220(1):9-19; PMID:9893163; http://dx.doi.org/10.3181/00379727-220-44338
   PubMed Web of Science ®Google Scholar
• Watson CS, Jeng YJ, Kochukov MY. Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci 2010; 115(1):1-11; PMID:19955490; http://dx.doi.org/10.1093/toxsci/kfp288
   PubMed Web of Science ®Google Scholar
• Jeng YJ, Watson CS. Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells - the involvement of rapidly activated kinases and caspases. BMC Cancer 2009; 9:334; PMID:19765307; http://dx.doi.org/10.1186/1471-2407-9-334
   PubMed Web of Science ®Google Scholar
• Vinas R, Jeng YJ, Watson CS. Non-genomic effects of xenoestrogen mixtures. Int J Environ Res Public Health 2012; 9(8):2694-714; PMID:23066391; http://dx.doi.org/10.3390/ijerph9082694
   PubMed Web of Science ®Google Scholar
• Watson CS, Jeng Y-J, Guptarak J. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol 2011; 127(1-2):44-50; PMID:21300151; http://dx.doi.org/10.1016/j.jsbmb.2011.01.015
   PubMed Web of Science ®Google Scholar
• Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: Influence of habitual diet. Proc Society Exp Biol Med 1998; 217(3):335-9; PMID:9492344; http://dx.doi.org/10.3181/00379727-217-44241
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012; 33(3):378-455; PMID:22419778; http://dx.doi.org/10.1210/er.2011-1050
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009; 30(1):75-95; PMID:19074586; http://dx.doi.org/10.1210/er.2008-0021
   PubMed Web of Science ®Google Scholar
• Vandenberg LN. Low-dose effects of hormones and endocrine disruptors. Vitam Horm 2014; 94:129-65; PMID:24388189; http://dx.doi.org/10.1016/B978-0-12-800095-3.00005-5
   PubMed Web of Science ®Google Scholar
• Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol 2012; 64(1):130-3; PMID:22750031; http://dx.doi.org/10.1016/j.yrtph.2012.06.015
   PubMed Web of Science ®Google Scholar
• Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptor-enriched GH3/B6 cells have an enhanced non-genomic response to estrogen. Endocrine 1995; 3:743-9; PMID:21153164; http://dx.doi.org/10.1007/BF03000207
   PubMed Web of Science ®Google Scholar
• Campbell CH, Watson CS. A comparison of membrane vs. intracellular estrogen receptor-α in GH(3)/B6 pituitary tumor cells using a quantitative plate immunoassay. Steroids 2001; 66(10):727-36; PMID:11522334; http://dx.doi.org/10.1016/S0039-128X(01)00106-4
   PubMed Web of Science ®Google Scholar
• Bulayeva NN, Watson CS. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Environ Health Perspect 2004; 112(15):1481-7
   PubMed Web of Science ®Google Scholar
• Vinas R, Watson CS. Mixtures of xenoestrogens disrupt estradiol-induced nongenomic signaling and functions in pituitary cells. BMC Environmental Health 2013; 12:26
   PubMed Web of Science ®Google Scholar
• Watson C, Jeng YJ, Kochukov M. Nongenomic actions of estradiol compared with estrone and estriol in pituitary tumor cell signaling and proliferation. FASEB J 2008; 22(9):3328-36; PMID:18541692; http://dx.doi.org/10.1096/fj.08-107672
   PubMed Web of Science ®Google Scholar
• Bulayeva NN, Gametchu B, Watson CS. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 2004; 69(3):181-92; PMID:15072920; http://dx.doi.org/10.1016/j.steroids.2003.12.003
   PubMed Web of Science ®Google Scholar
• Zivadinovic D, Watson CS. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 2005; 7(1):R130-44; PMID:15642162; http://dx.doi.org/10.1186/bcr959
   PubMed Web of Science ®Google Scholar
• Watson CS, Bulayeva NN, Wozniak AL, Alyea RA. Xenoestrogens are potent activators of nongenomic estrogenic responses. Steroids 2007; 72(2):124-34; PMID:17174995; http://dx.doi.org/10.1016/j.steroids.2006.11.002
   PubMed Web of Science ®Google Scholar
• Watson CS, Alyea RA, Jeng YJ, Kochukov MY. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 2007; 274(1-2):1-7; PMID:17601655; http://dx.doi.org/10.1016/j.mce.2007.05.011
   PubMed Web of Science ®Google Scholar
• Kochukov MY, Jeng YJ, Watson CS. Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3/B6/F10 somatomammotropes. Env Health Perspect 2009; 117(5):723-30; http://dx.doi.org/10.1289/ehp.0800182
   PubMed Web of Science ®Google Scholar
• Alyea RA, Watson CS. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. BMC Neurosci 2009; 10:59; PMID:19531209; http://dx.doi.org/10.1186/1471-2202-10-59
   PubMed Web of Science ®Google Scholar
• Jeng YJ, Kochukov M, Watson CS. Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Environ Health 2010; 9:61; PMID:20950447; http://dx.doi.org/10.1186/1476-069X-9-61
   PubMed Web of Science ®Google Scholar
• Jeng YJ, Watson CS. Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Environ Health Perspect 2011; 119(1):104-12
   PubMed Web of Science ®Google Scholar
• Watson CS, Jeng YJ, Guptarak J. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Bio Chem Mol Biol 2011; 127(1-2):44-50
   PubMed Web of Science ®Google Scholar
• Watson CS, Jeng YJ, Hu G, Wozniak A, Bulayeva N, Guptarak J. Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-alphai and caveolin I. Steroids 2011; 77(5):424-32; PMID:22230296
   PubMed Web of Science ®Google Scholar
• Vinas R, Watson CS. Rapid estrogenic signaling activities of modified (chlorinated, sulfonated, and glucuronidated) endocrine disruptor bisphenol A. Endocri Disruptors 2013; 1(1):e26306; PMID:24795899; http://dx.doi.org/10.4161/endo.25411
   Google Scholar
• Vinas R, Watson C. Bisphenol s disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect 2013; 121(3):352-8; PMID:23458715; http://dx.doi.org/10.1289/ehp.1205826
   PubMed Web of Science ®Google Scholar
• Koong LY, Watson CS: Direct estradiol and diethylstilbestrol actions on early- vs. late-stage prostate cancer cells. Prostate 2014; 74(16):1589-603
   PubMed Web of Science ®Google Scholar
• Koong LY, Watson CS. Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells. Endocrine Disruptors 2015; 3(1): e995003; http://dx.doi.org/10.4161/23273747.2014.995003.
   Google Scholar
• Alyea R, Laurence S, Kim S, Katzenellenbogen B, Katzenellenbogen J, Watson C. The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neuro Chem 2008; 106:1525-33
   PubMed Web of Science ®Google Scholar
• Narita M, Miyagawa K, Mizuo K, Yoshida T, Suzuki T. Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect. Neuro Sci Lett 2006; 402(3):249-52
   PubMed Web of Science ®Google Scholar
• Watson CS, Hu G, Paulucci-Holthauzen AA. Rapid actions of xenoestrogens disrupt normal estrogenic signaling. Steroids 2014; 81:36-42
   PubMed Web of Science ®Google Scholar
• Zivadinovic D, Gametchu B, Watson CS. Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 2005; 7(1):R101-12; http://dx.doi.org/10.1186/bcr958
   PubMed Web of Science ®Google Scholar
• Razandi M, Pedram A, Levin ER. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol Endocrinol 2000; 14(9):1434-47
   PubMed Web of Science ®Google Scholar
• Marquez DC, Pietras RJ. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 2001; 20(39):5420-30
   PubMed Web of Science ®Google Scholar
• Zarate S, Jaita G, Zaldivar V, Radl DB, Eijo G, Ferraris J, Pisera D, Seilicovich A. Estrogens exert a rapid apoptotic action in anterior pituitary cells. Am J Physiol Endocrinol Metab 2009; 296(4):E664-71
   PubMed Web of Science ®Google Scholar
• Christian HC, Morris JF. Rapid actions of 17beta-oestradiol on a subset of lactotrophs in the rat pituitary. J Physiol 2002; 539(Pt 2):557-66
   PubMed Web of Science ®Google Scholar
• Otto C, Fuchs I, Altmann H, Klewer M, Schwarz G, Bohlmann R, Nguyen D, Zorn L, Vonk R, Prelle K, et al. In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro. J Steroid BiochemMolBiol 2008; 111(1-2):95-100
   Google Scholar
• Lee HR, Hwang KA, Choi KC. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models. Int J Oncol 2014; 45(2):595-602
   PubMed Web of Science ®Google Scholar
• Alyea RA, Watson CS. Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol. Environ Health Perspect 2009; 117(5):778-83; http://dx.doi.org/10.1289/ehp.0800026
   PubMed Web of Science ®Google Scholar
• Bulayeva NN, Wozniak A, Lash LL, Watson CS. Mechanisms of membrane estrogen receptor-{α}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am J Physiol Endocrinol Metab 2005; 288:E388-97
   PubMed Web of Science ®Google Scholar
• Kits KS, Mansvelder HD. Regulation of exocytosis in neuroendocrine cells: spatial organization of channels and vesicles, stimulus-secretion coupling, calcium buffers and modulation. Brain Res Brain Res Rev 2000; 33(1):78-94
   PubMedGoogle Scholar
• Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003; 24(1):1-27
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002; 12(1):9-18
   PubMed Web of Science ®Google Scholar
• Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 2008; 22(4):954-65
   PubMed Web of Science ®Google Scholar
• Roskoski R, Jr. ERK1/2 MAP kinases: Structure, function, and regulation. Pharmacol Res 2012; 66(2):105-43
   PubMed Web of Science ®Google Scholar
• Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence. FEBS J 2010; 277(1):2-21; PMID:19843174; http://dx.doi.org/10.1111/j.1742-4658.2009.07366.x
   PubMed Web of Science ®Google Scholar
• Butt AJ, Caldon CE, McNeil CM, Swarbrick A, Musgrove EA, Sutherland RL. Cell cycle machinery: links with genesis and treatment of breast cancer. Adv Exp Med Biol 2008; 630:189-205; http://dx.doi.org/10.1007/978-0-387-78818-0_12
   PubMed Web of Science ®Google Scholar
• Valentin-Blasini L, Blount BC, Caudill SP, Needham LL: Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Expo Anal Environ Epidemiol 2003; 13(4):276-82; http://dx.doi.org/10.1038/sj.jea.7500278
   PubMedGoogle Scholar
• Brown NM, Belles CA, Lindley SL, Zimmer-Nechemias LD, Zhao X, Witte DP, Kim MO, Setchell KD. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. Carcinogenesis 2010; 31(5):886-93
   PubMed Web of Science ®Google Scholar
• Watson CS, Jeng YJ, Bulayeva NN, Finnerty CC, Koong LY, Zivadinovic D, Alyea RA, Midoro-Horiuti T, Goldblum RM, Anastasio NC, et al. Multi-well plate immunoassays for measuring signaling protein activations/deactivations and membrane vs. intracellular receptor levels. Methods Mol Biol 2014; 1204:123-33; http://dx.doi.org/10.1007/978-1-4939-1346-6_11
   PubMedGoogle Scholar
• Lottering ML, Haag M, Seegers JC. Effects of 17b-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 1992; 52:5926-32
   PubMed Web of Science ®Google Scholar